Listed

Equillium, Inc.

EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31

Reports and events: 158 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Equillium, Inc., Reports and events
FiledFormWhat it isAccession number
2021-04-0916:05 ETDEF 14AProxy statementPeriod 2021-05-260001564590-21-018327
2021-03-3016:52 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-016669
2021-03-2416:16 ET10-KAnnual reportPeriod 2020-12-310001564590-21-015103
2021-03-2416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-015101
2021-03-1508:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-013009
2021-03-0907:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-011597
2021-02-1617:21 ETSC 13DOwnership report, active investor0001104659-21-024389
2021-02-1215:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-005752
2021-02-0408:10 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-004194
2020-12-2108:06 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-322379
2020-12-0709:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-311281
2020-12-0409:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-310114
2020-11-3008:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-304969
2020-11-2508:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-303087
2020-11-1016:17 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-052979
2020-11-1016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-290153
2020-10-2917:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-281174
2020-09-2817:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-256711
2020-08-1416:50 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-220538
2020-08-1208:43 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-039503
2020-08-1208:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-217090
2020-08-1017:21 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-215058
2020-07-1406:08 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-192229
2020-07-1306:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-191424
2020-06-0108:04 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-156556
2020-05-2108:17 ET8-K5.07 Shareholder vote results0001564590-20-026454
2020-05-1316:16 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-025063
2020-05-1316:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-025054
2020-04-2416:30 ET8-K5.02 Departure or appointment of officers or directors0001564590-20-018536
2020-04-0316:15 ETDEF 14AProxy statementPeriod 2020-05-190001564590-20-015262
2020-03-3017:26 ETS-1Registration statement0001564590-20-014306
2020-03-3016:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001564590-20-014185
2020-03-2616:16 ET10-KAnnual reportPeriod 2019-12-310001564590-20-013207
2020-03-2616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-013200
2019-12-1207:05 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-312050
2019-11-2716:08 ET8-K8.01 Other events0001193125-19-302509
2019-11-1216:17 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-042933
2019-11-1216:10 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-19-042913
2019-10-0116:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-19-036089
2019-08-1216:16 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-031483
2019-08-1216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-031480
2019-06-1216:10 ET8-K5.07 Shareholder vote results0001564590-19-022336
2019-05-1316:21 ET10-QQuarterly reportPeriod 2019-03-310001564590-19-018839
2019-05-1316:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-018833
2019-05-0118:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-130143
2019-04-2516:15 ETDEF 14AProxy statementPeriod 2019-06-110001564590-19-013052
2019-03-2716:11 ET10-KAnnual reportPeriod 2018-12-310001564590-19-009580
2019-03-2716:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-009579
2019-02-2616:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-051928
2019-02-2016:08 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 8.01 Other events0001193125-19-045346

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:43 ET. Listed shows no prices and gives no investment advice.